Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Extramural Funding Opportunities

The following is a list of currently open non-limited extramural funding opportunties. Listings are generally updated in batches on a monthly basis. Entries are ordered by posting date, with most recent postings first. Funding opportunities are removed from this list once their final application due date has passed.

 

Posted March 24, 2015

American Society of Hematology Scholar Award

Application Due Date(s):  Letter of Intent Due May 1, 2015 / Application Due August 3, 2015

How to Apply: Visit the website here

Description: The ASH Scholar Award provides funding to support hematologists who have chosen career in research by providing partial salary or other support during that critical period required for completion of training and achievement of status as an independent investigator. This award supports both basic/translational research and clinical research.

This award provides a maximum of $100,000 for fellow scholars and $150,000 for junior faculty scholars over a two- to three-year period, with an annual maximum of $50,000 for fellows and $75,000 for junior faculty. Up to 15 percent of the award may be (but is not required to be) used for benefits, including medical and dental insurance, life insurance, and retirement benefits.


Alex’s Lemonade Stand Foundation (ALSF) ‘A’ Awards 

Application Due Date(s): May 22, 2015

How to Apply: Download the PDF here

Description: This grant is designed for early career scientists who want to establish their career in pediatric oncology research. The ideal applicant has an original project that is not currently funded. The goal is to advance research that will lead to new treatments and cures impacting children with cancer.

The ALSF’s ‘A’ Award provides $150,000 a year for three years. In addition, the ‘A’ Award provides reference books to enhance the recipient’s personal pediatric oncology library, up to $10,000 in equipment to enhance lab/project work, and registration fees for one educational course or event. Indirect costs are not allowed.


Alex’s  Lemonade Stand Foundation (ALSF) Reach Award

Application Due Date(s): May 29, 2015

How to Apply: Download the PDF here

Description: The purpose of the Reach Award is to advance ALSF’s mission to find cures and better treatments for childhood cancers by providing support to move hypothesis-driven research into the clinic. The Reach Award seeks to remove some of the barriers of moving a study from the pre-clinical arena into a clinical trial. Thus, the goal of this award is to support selected “late translational” studies needed to ultimately initiate a clinical trial. Preference will be given to those research projects which, if funded, will result in the initiation of a clinical trial within two to three years.

The Reach Award provides a maximum budget of $125,000 a year for two years in total costs. Budget items may include salary (maximum of 10 percent of grant per key investigator), fringe, travel, supplies and small pieces of equipment (less than $5,000). Indirect costs are not allowed.


Alex’s Lemonade Stand Foundation (ALSF) 2015 Bio-Therapeutics Impact Award (BTIA)

Application Due Date(s): June 30, 2015

How to Apply: Download the PDF here

Description: This award provides funding to support investigator-initiated clinical trials using biologic therapies, including but not limited to immunotherapy, gene therapy and small molecules. This grant category was initiated to accelerate the development of clinical trials for promising biologic approaches to treat childhood cancers through clinical trials.

A maximum of $1.5 million in total costs will be awarded over three years ($500,000 per year for three years). If applying for pre-clinical funding to perform IND enabling studies or have submitted an IND and are awaiting approval, funding will be capped at $100,000 in year one and the balance for the clinical trial initiation will be released after the IND is approved. The purchase of equipment is capped at $250,000 over three years.


Elsa U. Pardee Foundation Research Grant

Application Due Date(s): June 1, 2015

How to Apply: Visit the website here

Description: This grant provides funding to investigators in the U.S. that propose research directed toward identifying new treatments or cures for cancer. The Foundation particularly encourages grant applications for a one year period which will allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers. It is anticipated that this early stage funding by the Foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified.

There is no minimum or maximum set for the budget. However, most grants average $100,000-$150,000 for one year. Applications requesting more than 15% overhead are not usually considered for funding.


Lung Cancer Research Foundation 2015 Grant

Application Due Date(s): May 22, 2015

How to Apply: Download the PDF here

Description: The Lung Cancer Research Foundation's grant program provides critical seed support for cutting-edge scientific research on all cancers of the lung. The LCRF believes that this type of support can build proof of concept for researchers to apply for additional grant funding from universities and public sources. Lung cancer projects can be focused on basic science, translational research, clinical research, supportive care, and quality of care/outcomes.

This award provides up $50,000 for one year. All applicable costs including indirect/overhead costs must be included as part of requested budget total. Personnel budget lines must not account for more than 15 percent of total request. Funds may not be used for direct patient care costs that could be reimbursed from other sources.

 

Posted March 5, 2015

Damon Runyon Cancer Research Foundation (DRCRF) 2015 Damon Runyon-Sohn Pediatric Cancer Fellowship Award Overview 

Application Due Date(s): March 16, 2015

How to Apply: Visit the website here

Description: This award was created in conjunction with the Sohn Conference Foundation with the goal being to recruit top young minds dedicated to curing pediatric cancers. It provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or more pediatric cancers. Candidates must apply for fellowship under the guidance of a Sponsor – a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow.

The $150,000-$180,000 award will be for a period of three years with the second and third-year funding contingent upon satisfactory progress reports. Funding of $50,000-60,000 will be allocated to the awardee’s institution each year for the support of the Fellow. Fellows are permitted to obtain additional awards or grants to cover research expenses only and are required to obtain approval from the Foundation before applying for any other award or grant. There is also an additional $2,000 a year expense allowance that is awarded to the laboratory in which the Fellow is working. This is to be used by the Fellow for his/her educational and scientific expenses. It is not an allowance for institutional overhead, postdoctoral scholar registration fees or postdoctoral fellowship taxes. 

American Society of Hematology ASH-AMFDP Award

Application Due Date(s): March 18, 2015

How to Apply: Visit the website here

Description: The AMFDP offers four-year postdoctoral research awards to historically disadvantaged physicians who are committed to developing careers in academic medicine and to serving as role models for students and faculty of similar backgrounds. The program defines "historically disadvantaged" individuals as those who face challenges because of their race, ethnicity, socioeconomic status, or other similar factors.

This award provides an annual stipend of up to $105,000 a year for four years. This includes an annual stipend up to $75,000 and an annual grant of $30,000 toward the support of research activities. ASH-AMFDP Scholars are invited to the AMFDP and ASH annual meetings each year with travel expenses covered by the grant.

 

Posted February 5, 2015

V Foundation Translational Research Grant Program

Application Due Date(s): One-page proposal and biosketch need to be sent to Nancy Presseau at NPresseau@mednet.ucla.edu by Friday March 6, 2015 / Research proposal will be due by 5:00 PM EST on May 1, 2015 via the online portal.

How to Apply: Online portal expected to launch in early March. Please contact NPresseau@mednet.ucla.edu for your more information

Description: The Translational Research Grant Program supports research teams to conduct translational cancer research to bring laboratory discoveries to the patient bedside. The total amount of the grant is $600,000 awarded in three annual installments of $200,000 each.

Cancer Center Directors will nominate the applicant(s) to apply from their institution. Each invited cancer center director may nominate one principle investigator to lead a research team. Each PI may invite other researchers to work as collaborators on the research team.

All areas of cancer research are encouraged. For the 2015 Translational Program, The V Foundation has a special interest in supporting cancer research investigating cancers that are more prevalent or aggressive in specific ethnic populations (e.g., African Americans, Hispanic). Cancers in which ethnic and racial disparities have previously been shown include: lung and bronchus, colon and rectum, breast, prostate, uterine, cervix, stomach and liver. A limited number of Translational Grants will be awarded in this area.

 

Posted January 26, 2015

National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award for 2015

Application Due Date(s): Letter of Intent Due: February 15, 2015 / Full Proposals Due: March 1, 2015

How to Apply: Visit the website here

Description: The Cancer Clinical Investigator Team Leadership Award (CCITLA) is an administrative supplement award which recognizes and supports clinical investigators with an outstanding record of developing and promoting a culture of successful clinical research. It is the intent of the CCITLA to support mid-level clinical investigators at NCI-designated Cancer Centers who are participating extensively in NCI-funded collaborative clinical trials and clinical research efforts. The award is also intended to retain clinical investigators in academic clinical research careers. A candidate for the CCITLA must be nominated by the Cancer Center Director.


Tower Cancer Research Foundation Career Development Award

Application Due Date(s): Tuesday, March 31st, 2015

How to Apply: Visit the website here

Description: Career Development grantees will be awarded $100,000. Up to five Career Development grants will be awarded. The grant award must be used to cover research related expenses between July 1, 2015 and June 30, 2016. All grant awards are for one year only with no guarantee of renewal. Grant funds are to be applied towards salary, equipment and/or supplies. No use of funds for additional overhead expenses is permitted.


Tower Cancer Research Foundation Jessica M. Berman Memorial Fund Grant

Application Due Date(s): Letter of Intent Due: February 15, 2015 / Full Proposals Due: March 1, 2015

How to Apply: Visit the website here

Description: Senior investigator recipients of the Jessica M. Berman Memorial Fund Grant for will receive a $500,000 grant ($100,000 annually for 5 years, 2015-2020). The grant award must be used to cover research related expenses between July 1, 2015 and June 30, 2020. All grant awards are for 5 years only with no guarantee of renewal. Grant funds are to be applied towards salary, equipment and/or supplies. Grant funds are not permitted to be used for overhead expenses.

 

Posted December 1, 2014

Leukemia & Lymphoma Society (LLS) Translational Research Program

Application Due Date(s): Letter of Intent Receipt Date: February 6, 2015  / Application Receipt Date: March 13, 2015

How to Apply: Download the PDF here

Description: The LLS Translational Research Program was created in 1995 with the goal of accelerating clinical applications of laboratory findings relevant to improved diagnosis and management of leukemia, lymphoma, myeloma and other hematopoietic malignancies. In particular, the LLS Research staff and Medical and Scientific Affairs Committee encourage the submission of research proposals that are designed to accomplish one of the following:

  1. Define genetic/molecular predispositions to long-term and late-term effects associated
    with standard therapies in pediatric ALL and apply this information to improve patient
    outcomes
  2. Development of novel therapies and/or novel therapeutic strategies for patients with
    non-cutaneous T-cell lymphoproliferative disorders
  3. Development of novel therapies and/or novel therapeutic strategies for CLL patients, with real
    curative potential
  4. Development of novel therapies and/or novel therapeutic strategies for MDS and AML patients
  5. Development of novel therapies and/or novel therapeutic strategies for patients with high-risk
    myeloma
  6. Development of novel therapies and/or novel therapeutic strategies for indolent lymphoma
    patients

 

Posted September 5, 2014

California Breast Cancer Research Program Translational Research Award

Application Due Date(s): October 30, 2014 – Letter of Intent Due / March 12, 2015 – Full Application Due

How to Apply: Click here to download the PDF

Description: The purpose of this award is to support research that is on a critical path for practical application. Translational research to be supported by the CBCRP should have the potential for major impact in the any areas of:

  • Prevention, detection, diagnosis, or treatment of breast cancer
  • Improved quality of life for survivors
  • Reduction in the community and social burden caused by the disease in California
  • Advances in medical practices, health system changes, health policies, or environmental modifications

The total direct costs for this budget is capped at $750,000 over three years. UC institutional F&A is capped at 25 percent MTDC.

California Breast Cancer Research Program IDEA (Innovative, Developmental and Exploratory) Research Award

Application Due Date(s): October 30, 214 – Letter of Intent Due / March 12, 2015 – Full Application Due

How to Apply: Click here to download the PDF

Description: The purpose of this award is to support both established researchers and new investigators whose speculative, exploratory, high-risk/high-reward projects with a primary focus on breast cancer. Applications for this type of award should challenge existing paradigms, represent a new direction for the PI, and encourage innovation by the incorporation of techniques and approaches not yet well represented in mainstream breast cancer research. The CBCRC encourages researchers to attempt breakthroughs that, if successful, could be leveraged into more substantial funding.

The budget cap for this award is either $100,000 in direct costs or $150,000 in direct costs if using animal or human participants over an 18 month maximum duration. UC institutional F&A is capped at 25 percent MTDC.

California Breast Cancer Research Program Community Research Collaboration Award

Application Due Date(s): November 5, 2014 – Research Plan Due (optional) / March 12, 2015 – Full Application Due

How to Apply: Click here to download the PDF

Description: The California Breast Cancer Research Program (CBCRP) is seeking to fund community organizations to work in teams with well-trained, experienced research scientists. The teams work collaboratively through each stage of the research process, including: decision-making on which breast cancer questions are most important to them; determining the best research methods to use to answer these questions; gathering and interpreting data; and communicating findings to other community members, scientists, and the public, while generating results that can be applied to other communities. The goal of the CRC teams is to reduce the suffering caused by breast cancer by combining the existing knowledge, interest, expertise, and resources of communities and research scientists.

National Lung Cancer Partnership Free to Breathe 2015 Research Grant

Application Due Date(s): November 7, 2014 – Letter of Intent Due / March 9, 2015 – Full Application Due

How to Apply: Click here to download the PDF

Description: The Free to Breathe research grant solely focuses on research to prevent or stop lung cancer metastasis. They seek to support high-impact and innovative lung cancer research within this area of emphasis that will result in clinical translation (e.g. clinical trial) by the end of the 3-year award period. The ultimate goal is to fund research that will result in treatments for lung cancer patients and increase survival.

This grant provides $600,000, including a maximum of 8 percent ($48,000) indirect costs. Grants will be paid over three years at $200,000 per year. The second and third year payments will be contingent on receipt and approval of written progress reports. No more than 20 percent of the requested budget may be used for salary and fringe benefits for the principal investigator(s). 

Last updated: 3/24/2015 10:06:34 AM